Autopsy report · NCT02588248

L-Menthol Injection as a Novel Technique During Colonoscopy

“Sponsor/Investigator has decided to close out the study”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 7 months before it started.
• Ran for about 1 month before it stopped.
• 82 participants enrolled.
• Results were posted on the registry 4 years 11 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University Hospitals Cleveland Medical Center

Sponsor type

University, hospital or other

Conditions

Colonic Polyps; Colon Cancer

Interventions

Peppermint Oil; Placebo

Participants

82

Sites

1

Countries

United States

Trials that died the same way

• ML29255 Neoadjuvant Vemurafenib and Cobimetinib Melanoma
  “Sponsor has decided to close study.” (89% match in meaning)
• Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant
  “Study sponsor decided to close study.” (89% match in meaning)
• A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary
  “Sponsor Decision to close study” (88% match in meaning)
• A Study of ABP 215 Versus Bevacizumab in Chinese Subjects With Advanced Non-Squamous Non-Small Cell Lung Cancer
  “Sponsor decision to early terminate the study” (82% match in meaning)
• Study of Viziatek ISL™ Refractive Phakic Intra Sulcus Lens for Refraction Adjustment in Blind Volunteers
  “Sponsor decision to terminate the study” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.